CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .7. NEW HORIZONS IN BETA-ADRENOCEPTOR BLOCKADE THERAPY - LABETALOL

被引：52

作者：

FRISHMAN, W

HALPRIN, S

机构：

来源：

关键词：

D O I：

10.1016/0002-8703(79)90294-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：660 / 665

页数：6

共 41 条

[21] KOCH G, 1976, BRIT J CLIN PHARMACO, V3, P725
[22] MARTIN LE, 1976, BRIT J CLIN PHARMACO, V3, P695
[23] CORONARY VASOSPASM AS A POSSIBLE CAUSE OF MYOCARDIAL-INFARCTION - CONCLUSION DERIVED FROM STUDY OF PREINFARCTION ANGINA
MASERI, A
LABBATE, A
BAROLDI, G
CHIERCHIA, S
MARZILLI, M
BALLESTRA, AM
SEVERI, S
PARODI, O
BIAGINI, A
DISTANTE, A
PESOLA, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (23) : 1271 - 1277
[24] MAXWELL GM, 1973, BRIT J PHARMACOL, V44, P270
[25] HEMODYNAMIC EFFECTS OF LABETALOL, AN ALPHA AND BETA-ADRENERGIC BLOCKING-AGENT, IN HYPERTENSIVE SUBJECTS
MEHTA, J
COHN, JN
[J]. CIRCULATION, 1977, 55 (02) : 370 - 375
[26] PATEL KR, 1975, LANCET, V1, P348
[27] PEARSON RM, 1976, BRIT J CLIN PHARMACO, V3, P795
[28] POYNTER D, 1976, BRIT J CLIN PHARMACO, V3, P711
[29] PRICHARD BNC, 1976, BRIT J CLIN PHARMACO, V3, P743
[30] PUGSLEY DJ, 1976, BRIT J CLIN PHARMACO, V3, P777